Pharmacological evidence of hypotensive activity of Somina (herbal drug) in normotensive rats
Purpose: To evaluate the effects of somina (herbal drug) on the arterial blood pressure.
Methods: Hypotensive activity was studied in pentothal sodium-anesthetized normotensive albino rats at various doses of somina (5, 10, 15, 20 and 35 mg/kg). The drugs were administered intravenously and changes in arterial blood pressure (systolic, diastolic and mean arterial blood pressure) were registered directly from the carotid artery. Acetylcholine (Ach, 10-4 M) was used as positive control for comparison while the receptor activity of Ach and somina was assessed using atropine (muscarinic receptor antagonist) on rat heart.
Results: Somina caused dose-dependent significant (p < 0.05) reduction in mean arterial pressure blood pressure (MABP). The 35 mg/kg dose caused 46.7 % fall in MABP, which was significant (p < 0.05) when compared with control. The results were comparable with those of acetylcholine (10-4 M) which showed 45.6 % fall in MABP. For receptor activity, atropine (10-4 M) was administered i.v., and then the Ach and somina (45 mg/kg) was administered one at a time. Non-significant fall in MABP was observed (1.2 and 20 %, p > 0.05) in rats that were pretreated with atropine.
Conclusion: Somina possesses potent hypotensive effect at different doses in normal rats by stimulating non-selective muscarinic receptors.
Keywords: Somina, Acetylcholine, Atropine, Herbal drug, Blood pressure, Hypotensive activity, Muscarinic receptor, Vascular relaxant activity
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.